Myriad Genetics Inc (MYGN)
18.49
-0.01
(-0.05%)
USD |
NASDAQ |
Apr 22, 16:00
18.49
0.00 (0.00%)
Pre-Market: 20:00
Myriad Genetics Total Assets (Quarterly): 1.146B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.146B |
| September 30, 2023 | 1.149B |
| June 30, 2023 | 1.187B |
| March 31, 2023 | 1.169B |
| December 31, 2022 | 1.199B |
| September 30, 2022 | 1.212B |
| June 30, 2022 | 1.210B |
| March 31, 2022 | 1.255B |
| December 31, 2021 | 1.321B |
| September 30, 2021 | 1.336B |
| June 30, 2021 | 1.360B |
| March 31, 2021 | 1.337B |
| September 30, 2020 | 1.444B |
| June 30, 2020 | 1.405B |
| March 31, 2020 | 1.447B |
| December 31, 2019 | 1.578B |
| September 30, 2019 | 1.591B |
| June 30, 2019 | 1.563B |
| March 31, 2019 | 1.557B |
| December 31, 2018 | 1.557B |
| September 30, 2018 | 1.574B |
| June 30, 2018 | 1.175B |
| March 31, 2018 | 1.218B |
| December 31, 2017 | 1.228B |
| September 30, 2017 | 1.228B |
| Date | Value |
|---|---|
| June 30, 2017 | 1.209B |
| March 31, 2017 | 1.268B |
| December 31, 2016 | 1.276B |
| September 30, 2016 | 1.271B |
| June 30, 2016 | 880.50M |
| March 31, 2016 | 868.20M |
| December 31, 2015 | 871.70M |
| September 30, 2015 | 787.00M |
| June 30, 2015 | 766.20M |
| March 31, 2015 | 779.05M |
| December 31, 2014 | 781.85M |
| September 30, 2014 | 809.01M |
| June 30, 2014 | 823.80M |
| March 31, 2014 | 816.43M |
| December 31, 2013 | 756.68M |
| September 30, 2013 | 781.66M |
| June 30, 2013 | 803.82M |
| March 31, 2013 | 729.03M |
| December 31, 2012 | 717.75M |
| September 30, 2012 | 703.06M |
| June 30, 2012 | 690.64M |
| March 31, 2012 | 699.25M |
| December 31, 2011 | 661.26M |
| September 30, 2011 | 619.74M |
| June 30, 2011 | 610.83M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.146B
Minimum
Dec 2023
1.591B
Maximum
Sep 2019
1.328B
Average
1.328B
Median
Total Assets (Quarterly) Benchmarks
| Stryker Corp | 39.91B |
| Haemonetics Corp | 2.200B |
| Perspective Therapeutics Inc | 97.89M |
| Electromed Inc | 46.96M |
| Xtant Medical Holdings Inc | 92.61M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 363.30M |
| Shareholders Equity (Quarterly) | 783.20M |
| Debt to Equity Ratio | 0.0492 |
| Current Ratio | 2.012 |
| Net Debt Paydown Yield | -0.45% |